Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...
NEW YORK — New insights into colchicine's disruption of the pathway that contributes to arterial inflammation and new clinical studies of the drug could pave the way toward greater use of the ...
BASEL, Switzerland—Low-dose colchicine doesn’t significantly reduce MACE in patients who have had a nonsevere ischemic stroke or high-risk TIA, according to the results of the CONVINCE trial. Through ...
Please provide your email address to receive an email when new articles are posted on . In patients referred for PCI after acute heart attack, colchicine did not improve heart-related outcomes vs.
Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.
Dear Dr. Roach: I’m a 78-year-old man with a stent and a blockage in one of the arteries to my heart. I am on a low-fat diet and take ramipril for cholesterol. My levels are very good (total ...
Can you explain the recent confusion surrounding the generic availability of colchicine? Why is there only 1 brand of colchicine product available? It is also important to note that colchicine often ...
A new study from the LoDoCo2 trial has found that taking a small daily dose of a drug called colchicine might help people ...
NEW YORK (Reuters Health) - Two recent deaths, and possibly a third, from intravenous colchicine therapy at an alternative medicine clinic were the result of a compounding pharmacy error, health ...
Colchicine is a potent anti‐inflammatory agent widely employed in the treatment of gout and related conditions. However, its narrow therapeutic window renders it a considerable toxicological risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results